Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cerno Bioscience is a life science software company that specializes in improving the accuracy and capabilities of mass spectrometry (MS) data. The company's flagship product, MassWorks, utilizes patented calibration technologies to significantly enhance the mass accuracy and spectral quality of data from various MS instruments, including low-resolution systems. This allows researchers to perform accurate formula identification and mixture analysis that would otherwise require much more expensive, high-resolution hardware. Cerno's solutions are widely used in pharmaceutical research, environmental testing, and chemical analysis to streamline workflows and improve data reliability. The technology is compatible with data from all major mass spectrometer manufacturers, making it a versatile tool for analytical laboratories.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cerno Bioscience.